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A 72-year-old woman was admitted to our hospital for esophagectomy for esophageal cancer. On the third postoperative day,
she developed polyuria (3.8L/day), massive natriuresis, hyponatremia (112mEq/L), hyperkalemia (5.6mEq/L), and decreased
central venous pressure, which was refractory to isotonic saline infusion. Laboratory ﬁndings indicated proximal tubular injury
(high urinary β2-microglobulin, coexistence of hypouricemia) together with reduced aldosterone action at the cortical collecting
duct. A diagnosis of salt-losing nephropathy was made and sodium correction was done with 3% saline and ﬂudrocortisone. She
respondedwelltotherapy.Thecauseofhyponatremiawasconsideredrenaltubulardysfunctiontogetherwithelevatedantidiuretic
hormone level. Postoperatively, it is important to look for the development of salt-losing nephropathy.
Copyright © 2009 Katsunobu Yoshioka et al. This is an open access article distributed under the Creative Commons Attribution
License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly
cited.
1.Introduction
Postoperative hyponatremia is usually attributed to the syn-
drome of inappropriate secretion of antidiuretic hormone
(SIADH), which results from administration of excessive
ﬂuid in the presence of nonosmotic secretion of ADH [1]. In
this setting, electrolyte-free water is retained in the body, and
extracellular ﬂuid volume (ECV) is expanded. On the other
hand, salt-losing nephropathy (SLN) is deﬁned as a renal
loss of sodium that leads to hyponatremia and ECV loss [2].
Diﬀerentiation of SLN from SIADH is important because
treatment of SLN is opposite from that of SIADH. However,
diﬀerentiation of these disorders is problematic because
clinical and laboratory ﬁndings are similar and evaluation of
ECVstatusisdiﬃcult.Here,wereportacaseofpostoperative
hyponatremia attributed to SLN in which the patient’s ECV
status was monitored by measuring central venous pressure
(CVP), hematocrit value, and water balance. Furthermore,
we describe the underlying mechanisms of natriuresis in the
present case.
2.CaseReport
A 72-year-old woman was admitted to our hospital for
surgery for esophageal cancer. At admission, her blood
pressure was 120/70mmHg and pulse rate was 76 beats
per minute. She was 152cm in height and weighted
62Kg. Physical examination was unremarkable. Preopera-
tively, renal function was moderately decreased (creatinine,
0.95mg/dL, blood urea nitrogen: 16.5mg/dL, uric acid:
5.7mg/dL, sodium: 144mEq/L, potassium: 4.1mEq/L, chlo-
ride 110mEq/L, phosphorus 3.7mg/dL). During the tho-
racoscopic esophagectomy, blood loss was 460ml, and
hemodynamics were stable.
Postoperatively, approximately 2L of hypotonic ﬂuid
(0.2% saline with 4.3% dextrose) daily were adminis-
tered, urine volume was stable (1.1–1.8L), and plasma
sodium levels were unchanged (140mEq/L). However, on
the third postoperative day, she suddenly developed polyuria
(3.8L/day) together with a decrease in CVP (Figure 1).
Serum sodium levels dropped to 124mEq/L on the next day.2 Case Reports in Medicine
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Figure 1: Clinical course.
Despite volume-to-volume correction with isotonic saline,
the serum sodium levels dropped to a nadir of 112mEq/L
together with hyperkalemia (5.6mEq/L) on the ﬁfth postop-
erative day, and her consciousness level deteriorated. When
her urine volume was 3.8L and 3.5L, there was a negative
water balance (without including perspiration); −0.9Land
−0.5L, respectively. The hematocrit value increased from
27.4%to33.7%duringthe2dayswithoutbloodtransfusion.
The next day, our department was consulted for further
evaluation. She appeared dehydrated and there was an
additional decrease in her CVP to a nadir of 1cm of H2O.
Laboratory ﬁndings on consultation are shown in Table 1.
Urinary sodium concentrations were markedly high and
serum uric acid levels were decreased from 5.7mg/dL to
1.4mg/dL. Urinary N-acetyl-β-glucosamininase (NAG) and
β2-microglobulin were high and the calculated maximal
tubularreabsorptionofphosphorusperglomerularﬁltration
rate (TmP/GFR) was relatively low (2.4mg/dL), suggesting
proximal tubule dysfunction. Furthermore, the calculated
transtubular potassium gradient (TTKG) value was low
(3.6) for her serum potassium levels (4.7mEq/L), suggesting
that aldosterone action at cortical collecting duct (CCD)
was impaired. These features were not consistency with the
diagnosis of a SIADH. Thus, she was diagnosed as having
SLN due to renal tubular dysfunction. Sodium correction
was done with 3% saline and ﬂudrocortisone was started at
a dose of 0.05mg/day. Thereafter, urinary volume decreased
and there was a gradual increase in serum sodium levels
to 138mEq/L and serum uric acid levels to 3.4mg/dL.
Her consciousness level completely recovered. On the 20th
postoperative day ﬂudrocortisone was discontinued and she
was discharged. She has been followed as an outpatient
without recurrence of the hyponatremia.
3. Discussion
The present case developed hyponatremia on the fourth
postoperative day together with increased urine volume,
a negative balance for water, an increase in hematocrit
values, and decreased CVP. Thus, ECV status was considered
hypovolemic, which was not consistency with the diagnosis
of a SIADH.
The cause of hypovolemic hyponatremia was thought to
be renal loss because urinary sodium concentrations were
high. The cause of renal loss includes diuretic use, adrenal
insuﬃciency, osmotic diuresis, cerebral salt wasting syn-
drome (CSWS), and SLN. Diuretic use, adrenal insuﬃciency,
andosmoticdiuresiswereruledoutclinicallyandendocrino-
logically. CSWS was introduced in 1950 [3], when it was
used to describe renal salt wasting caused by intracranial
disease.Consideringthatthepresentcasehadnointracranial
disease, it was unlikely that the cause of hyponatremia was
CSWS. Some researchers claim that “SLN” does not exist.
However, Maesaka presented evidence of renal salt wasting
inahyponatremicpatientandrecommendedtheelimination
of “cerebral” in favor of “renal” in salt-wasting syndrome, as
the absence of clinical cerebral disease would eliminate renal
salt wasting from the diﬀerential diagnosis when evaluating
thehyponatremicpatient[4].Thus,“SLN”doesexistandthe
cause of hyponatremia in the present case was considered to
be SLN.
We believe that proximal tubular dysfunction existed
in the present case. First, urinary concentrations of β2-
microglobulin and NAG were high, suggesting proximal
tubular injury and dysfunction. Second, hyponatremia and
hypouricemia coexisted despite ECV depletion. The reab-
sorption of urate occurs mainly in the proximal tubule and
is indirectly coupled to sodium reabsorption [5]. Patients
with ECV depletion generally have hyperuricemia, because
proximal tubules avidly reabsorb sodium together with
urate. Therefore, the coexistence of ECV depletion and
hypouricemia suggested proximal tubular dysfunction and
injury. To show that reabsorption of urate is disturbed, it
is essential to calculate fractional excretion of urate (FEUA).
Unfortunately, urinary urate was not measured at the ﬁrst
account. We measured urinary urate after her serum urate
increase to 3.4mg/dL, when her FEUA was high at a level of
11.5%. This observation suggest that reabsorption of urate
should have been severely disturbed when her serum urate
was 1.4mg/dL. Third, TmP/GFR was relatively low, which is
characteristics of SLN and not of SIADH.
We considered that not only proximal tubule but also
another segment of renal tubules were aﬀected, because if
the proximal tubule is the only aﬀected tubule, more distal
tubules can compensate for reduced proximal tubule sodium
reabsorption and severe hyponatremia rarely occurs. Final
regulation of sodium resbsorption is done at the CCD. The
coexistence of hyperkalemia and hyponatremia, although
hyperkalemia is an unusual presentation of SLN, led us toCase Reports in Medicine 3
Table 1: Laboratory data on consultation.
Urinalysis Biochemistry Endocrinolgy
Osmolality 766mOsm/l Osmolality 251mOsm/l Cortisol 30.7μg/dL (4–23.3)
Sodium 166mEq/L Sodium 119mEq/L ACTH 29pg/ml (7–56)
Potassium 52mEq/L Potassium 4.7mEq/L Aldosterone 161pg/ml
Chloride 183mEq/L Chloride 88mEq/L PRA 1.3ng/ml/h
β2-microglobulin 9.3mg/l Calcium 8.0mg/dL AVP 9.96pg/ml
(<0.17) Phosphorus 3.2mg/dL freeT4 1.7ng/ml (0.9–1.7)
NAG 41.0IU/l (0.7–11.2) Creatinine 0.5mg/dL TSH 1.22μIU/ml (0.5–5)
TTKG 3.6 BUN 17.8mg/dL Cytokines
TmP/GFR 2.4mg/dL Uric acid 1.4mg/dL IL- 6 34.8pg/ml (<0.4)
Glucose 187mg/dL TNF-α< 5pg/ml(<0.5)
NAG: N-acetyl-β-glucosamininase, TTKG: transtubular potassium gradient, TmP/GFR: maximal tubular reabsorption of phosphorus per glomerular
ﬁltration rate, BUN: blood urea nitrogen, ACTH: adrenocorticotropic hormone, PRA: plasma renin activity, AVP: arginine vasopressin, T4: thyroxine, T3:
triiodothyroxine, TSH: thyroid stimulating hormone, IL-6: Interleukin-6, TNF-α: tumor necrosis factor-α
suspect that the CCD could not compensate for reduced
proximal tubule sodium reabsorption due to refractoriness
to aldosterone. Under conditions of maximal aldosterone
action, the TTKG should be 7–10. In the present case,
however, TTKG was 3.6, suggesting aldosterone action was
suppressed.
Because ﬁnal regulation of free water is done at the
medullary collecting duct via the action of ADH, sodium
loss itself does not necessarily cause hyponatremia. The ﬁnal
cause of hyponatremia was considered elevated ADH level
for her plasma osmolality together with increased urinary
sodium loss and intake of free water due to infusion of hypo-
tonic ﬂuid. Causes of nonosmotic secretion of ADH in the
present case include ECV depletion and postoperative stress.
To suppress ADH secretion, volume load was done with 3%
saline infusion, and ﬂudrocrotisone, which acts directly on
the CCD, was administrated. The patient responded well to
this treatment.
Postoperative hyponatremia occurs despite near-isotonic
saline infusion in which hyponatremia is caused by genera-
tion of electrolyte-free water during excretion of hypertonic
urine; this is referred to as desalination phenomenon
[1]. Although the precise mechanism underlying this phe-
nomenon in not elucidated, the most important factor is the
amountofsalinethatwasinfusedtomaintainbloodpressure
during anesthesia. Thus, it is possible that we were just
observing desalination phenomenon. However, in reported
cases of desalination phenomenon, hyponatremia occurred
within 24 hours after surgery and the water balance was
positive. So, this mechanism was unlikely in the present case.
We therefore considered that a natriuresis factor other than
desalination phenomenon existed in the present case.
The driving force for proximal tubule Na reabsorption
depends on electrochemical gradients generated by Na/K
ATPase at the basolateral membrane. Endothelial derived
inﬂammatory cytokines, mediated by nitric oxide produc-
tion, reduce proximal tubule Na reabsorption by downreg-
ulation of Na/K ATPase activity [6]. In some pathological
conditions such as systemic-onset juvenile arthritis [7]a n d
Adult still’s disease [8], systemic inﬂammatory responses
are associated with abnormal Na transport which is involved
in the pathogenesis of SLN [9]. Furthermore, reduction in
Na transport due to inﬂammatory cytokines is refractory
to aldosterone because the epithelial sodium channel at the
apical membrane is also downregulated [9]. Major surgery
induces a severe inﬂammatory response that may be related
to the development of severe postoperative complications
[10]. In the present case serum levels of interleukin 6 (IL-6)
were elevated (34.8pg/mL). Thus, postoperative inﬂamma-
tory cytokines may be one mechanism for reduced proximal
tubule Na reabsorption. However, the elevation of IL-6 was
mild and other mechanisms such as pressure natriuresis due
tolargeadrenergicsurgemaybeinvolvedinthemechanisms.
Adrenergic surge may cause renal vasodilation and increase
GFR.Asaresult,serumcreatininecouldbedecreaseddespite
dehydration.
In summary, we encountered a patient who developed
severe hyponatremia after esophagectomy for esophageal
cancer. The cause of hyponatremia was considered renal
tubular dysfunction together with elevated ADH level.
Postoperatively, it is important to look for the development
of SLN for proper management.
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